Lucid Diagnostics Inc.
LUCD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $41,357 | $58,876 | $49,194 | $193,629 |
| - Cash | $22,358 | $18,896 | $22,474 | $53,656 |
| + Debt | $21,254 | $15,255 | $1,999 | $0 |
| Enterprise Value | $40,253 | $55,235 | $28,719 | $139,973 |
| Revenue | $4,346 | $2,428 | $377 | $500 |
| % Growth | 79% | 544% | -24.6% | – |
| Gross Profit | -$3,920 | -$6,050 | -$3,237 | -$85 |
| % Margin | -90.2% | -249.2% | -858.6% | -17% |
| EBITDA | -$44,336 | -$49,751 | -$54,235 | -$27,415 |
| % Margin | -1,020.2% | -2,049.1% | -14,385.9% | -5,483% |
| Net Income | -$45,529 | -$52,666 | -$56,171 | -$28,078 |
| % Margin | -1,047.6% | -2,169.1% | -14,899.5% | -5,615.6% |
| EPS Diluted | -1.05 | -1.26 | -1.55 | -0.78 |
| % Growth | 16.7% | 18.7% | -98.7% | – |
| Operating Cash Flow | -$44,140 | -$32,817 | -$29,685 | -$17,668 |
| Capital Expenditures | -$646 | -$221 | -$908 | -$862 |
| Free Cash Flow | -$44,786 | -$33,038 | -$30,593 | -$18,530 |